In mammals, fetal cardiac myocytes (CMs) proliferate robustly, contributing to the growth of the heart in utero. Postnatally, cell cycle genes are dramatically down-regulated and the ability of CMs to enter the cell cycle is lost after postnatal day 7. The lack of cell cycle gene expression in adult CMs (ACMs) suggests these genes are stably silenced and no longer able to respond to growth stimuli. As a result of this very limited proliferative potential, the mammalian heart has long been thought of as a non-regenerative organ. This has been challenged by increasing evidence demonstrating that postnatal CMs do proliferate and contribute to myocardial renewal but at a very low rate. The lack of cell cycle gene expression in ACMs is reminiscent of other biologic processes such as senescence or cell cycle checkpoints where epigenetic mechanisms stably silence gene transcription through the formation of heterochromatin. This proposal hypothesizes that cell cycle genes are stably silenced in ACMs through a highly regulated process that involves trimethylation of histone H3 on lysine 9 (H3K9me3), which then recruits the epigenetic machinery at cell cycle promoters leading to stable gene silencing. The corollary of this model, if true, is that manipulating this epigenetic process and the proteins that mediate heterochromatin formation could promote cell cycle re-entry in ACMs, a first step towards cardiac proliferation and myocardial regeneration. PHS 398/2590 (Rev. 11/07) Page Continuation Format Page
Myocardial regeneration to restore cardiac muscle mass after injury has been proposed as a means to prevent the development of congestive heart failure for decades. Developing strategies to repair the infarcted heart by stimulating proliferation of endogenous cardiac myocytes holds great promise as a therapeutic strategy. The studies in this application will address critical deficiencies in our current knowledge and develop clinically relevant approaches to repair the infarcted heart.
| Oyama, Kyohei; El-Nachef, Danny; Fang, Chen et al. (2018) Deletion of HP1? in cardiac myocytes affects H4K20me3 levels but does not impact cardiac growth. Epigenetics Chromatin 11:18 |
| El-Nachef, Danny; Oyama, Kyohei; Wu, Yun-Yu et al. (2018) Repressive histone methylation regulates cardiac myocyte cell cycle exit. J Mol Cell Cardiol 121:1-12 |
| Zhang, Yiqiang; Mignone, John; MacLellan, W Robb (2015) Cardiac Regeneration and Stem Cells. Physiol Rev 95:1189-204 |
| Oyama, Kyohei; El-Nachef, Danny; Zhang, Yiqiang et al. (2014) Epigenetic regulation of cardiac myocyte differentiation. Front Genet 5:375 |
| Gago-Lopez, Nuria; Awaji, Obinna; Zhang, Yiqiang et al. (2014) THY-1 receptor expression differentiates cardiosphere-derived cells with divergent cardiogenic differentiation potential. Stem Cell Reports 2:576-91 |
| Sdek, Patima; Oyama, Kyohei; Angelis, Ekaterini et al. (2013) Epigenetic regulation of myogenic gene expression by heterochromatin protein 1 alpha. PLoS One 8:e58319 |
| Ahuja, Preeti; Wanagat, Jonathan; Wang, Zhihua et al. (2013) Divergent mitochondrial biogenesis responses in human cardiomyopathy. Circulation 127:1957-67 |
| Oyama, Kyohei; El-Nachef, Danny; MacLellan, W Robb (2013) Regeneration potential of adult cardiac myocytes. Cell Res 23:978-9 |
| Weiss, James N; Karma, Alain; MacLellan, W Robb et al. (2012) ""Good enough solutions"" and the genetics of complex diseases. Circ Res 111:493-504 |
| Nsair, Ali; Schenke-Layland, Katja; Van Handel, Ben et al. (2012) Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cells. PLoS One 7:e45603 |
Showing the most recent 10 out of 29 publications
